Produktbild: Prostate Cancer

Prostate Cancer A Multidisciplinary Approach to Diagnosis and Management

146,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

17.12.2014

Herausgeber

Adam P. Dicker + weitere

Verlag

Springer Publishing

Seitenzahl

400

Maße (L/B/H)

27,9/21,6/2,1 cm

Gewicht

1429 g

Sprache

Englisch

ISBN

978-1-936287-59-8

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

17.12.2014

Herausgeber

Verlag

Springer Publishing

Seitenzahl

400

Maße (L/B/H)

27,9/21,6/2,1 cm

Gewicht

1429 g

Sprache

Englisch

ISBN

978-1-936287-59-8

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Prostate Cancer
  • ;

    Contributors

    ;

    Series Foreword

    ;

    Preface

    ;

    Acknowledgments

    ;

    I.

    ;

    Epidemiology, Screening, and Diagnosis

    ;

    1 Introduction: The Multidisciplinary Approach to Prostate Cancer

    ;

    Leonard G. Gomella

    ;

    2.1 Epidemiology of Prostate Cancer

    ;

    Kathryn M. Wilson

    ;

    Lorelei A. Mucci

    ;

    2.2 Diet and Prostate Cancer

    ;

    James R. Marshall

    ;

    2.3 Epidemiology: Obesity as a Risk Factor

    ;

    Emma H. Allott

    ;

    Stephen J. Freedland

    ;

    3.1.1 Screening and Diagnosis: The Pros of PSA Screening

    ;

    Janine L. Oliver

    ;

    Gurdarshan S. Sandhu

    ;

    Gerald L. Andriole

    ;

    Robert L. Grubb III

    ;

    3.1.2 The Argument Against Prostate Cancer Screening

    ;

    Otis W. Brawley

    ;

    3.1.3 How Do We Improve PSA Accuracy?

    ;

    Toru Sugihara

    ;

    Michael W. Kattan

    ;

    3.2 Screening and Diagnosis: An Update on the ISUP-Modified Gleason Score and Its Controversies

    ;

    Ibrahim Kulac

    ;

    Angelo M. DeMarzo

    ;

    3.3 Evaluation of Distant Disease: The Utility of Nuclear Imaging

    ;

    Dima Raskolnikov

    ;

    Baris Turkbey

    ;

    Liza Lindenberg

    ;

    Peter L. Choyke

    ;

    Peter A. Pinto

    ;

    4 Current Approaches to Prostate Cancer Staging and Risk Stratification: In the Midst of a Paradigm Shift

    ;

    Chad A. Reichard

    ;

    Eric A. Klein

    ;

    5.1 Novel Molecular and Genotype Profiling in Prostate Cancer: The Future of Screening, Diagnosis, and Staging

    ;

    Heesun Shin

    ;

    Ismael A. Vergara

    ;

    Anirban P. Mitra

    ;

    Timothy J. Triche

    ;

    Elai Davicioni

    ;

    5.2 Genomics and Risk Assessment

    ;

    Hao G. Nguyen

    ;

    Matthew R. Cooperberg

    ;

    Peter R. Carroll

    ;

    5.3 Future Direction: Novel Urine and Serum Markers

    ;

    Waleed A. Hassen

    ;

    5.4 Morphometric and Systems Pathology: The Future of Screening, Diagnosis, and Staging

    ;

    Michael J. Donovan

    ;

    Faisal M. Khan
    Richard Scott

    ;

    Gerardo Fernandez

    ;

    Carlos Cordon-Cardo

    ;

    5.5.1 PET: The Future of Screening, Diagnosis, and Staging for Prostate Cancer

    ;

    Mathew L. Thakur

    ;

    Edouard J. Trabulsi

    ;

    Sung M. Kim

    ;

    Charles M. Intenzo

    ;

    Leonard G. Gomella

    ;

    5.5.2 DCE MRI and MR Spectroscopy: The Future of Screening, Diagnosis, and Staging

    ;

    Victor Sai

    ;

    Antonio C. Westphalen

    ;

    5.5.3 Future Direction: Contrast Ultrasound 109

    ;

    Sanjay Kasturi

    ;

    Edouard J. Trabulsi

    ;

    Ethan J. Halpern

    ;

    6 Counseling Patients With Clinically Localized, High-Risk Prostate Cancer

    ;

    Jonathan L. Silberstein

    ;

    James A. Eastham

    ;

    II.

    ;

    Treatment for Low-Risk, Localized Disease

    ;

    7 Active Surveillance for Prostate Cancer: An Overview

    ;

    Laurence Klotz

    ;

    8 Treatment of Low-Risk, Localized Prostate Cancer: A Holistic Approach With Diet

    ;

    Jillian Scambia

    ;

    Annie DarvesñBornoz

    ;

    Aaron Katz

    ;

    9.1 Traditional Radical Prostatectomy

    ;

    Zachary L. Smith

    ;

    Thomas J. Guzzo

    ;

    9.2 Laparoscopic Radical Prostatectomy: Techniques and Complications

    ;

    Fernando Pablo Secin

    ;

    Karim Touijer

    ;

    9.3 Robotic Radical Prostatectomy: The Thomas Jefferson University Experience

    ;

    Costas D. Lallas

    ;

    Edouard J. Trabulsi

    ;

    9.4 Surgical Training, Digital Capture, Virtual Reality, and the Future of Radical Prostatectomy

    ;

    Costas D. Lallas

    ;

    10.1.1 External Beam Radiation Therapy: Conventional Fractionation

    ;

    David E. Greene

    ;

    Richard K. Valicenti

    ;

    10.1.2 Hypofractionated Radiation Therapy for Localized Prostate Cancer

    ;

    Nicholas G. Zaorsky

    ;

    Robert B. Den

    ;

    10.1.3 Stereotactic Body Radiation Therapy for Localized Prostate Cancer

    ;

    Nicholas G. Zaorsky

    ;

    Robert B. Den

    ;

    10.1.4 Treatment of Low-Risk, Localized Prostate Cancer: Use of Proton Therapy

    ;

    Phillip J. Gray

    ;

    Ayal A. Aizer

    ;

    Jason A. Efstathiou

    ;

    10.2 Treatment of Low-Risk, Localized Prostate Cancer: Brachytherapy

    ;

    Peter Grimm

    ;

    11.1 Treatment of Low-Risk, Localized Prostate Cancer: General Principles of Ablative and Focal Therapies

    ;

    Joshua A. Cohn

    ;

    Aytekin Oto

    ;

    Scott E. Eggener

    ;

    11.2 Hyperthermia for Prostate Cancer

    ;

    Mark Hurwitz

    ;

    11.3 Ablative Techniques: Vascular Targeted Photodynamic Therapy

    ;

    Ashley G. Winter

    ;

    Jonathan A. Coleman

    ;

    11.4 Laser Ablative Techniques for Prostate Cancer

    ;

    Ashley G. Winter

    ;

    Jonathan A. Coleman

    ;

    11.5 Irreversible Electroporation (IRE) Prostate Ablation

    ;

    Ashley G. Winter

    ;

    Jonathan A. Coleman

    ;

    12.1 Quality of Life With Surgery

    ;

    Alana M. Murphy

    ;

    Patrick J. Shenot

    ;

    12.2 Quality of Life With Androgen Deprivation Therapy

    ;

    Alana M. Murphy

    ;

    Patrick J. Shenot

    ;

    12.3 Quality of Life With External Beam Radiation Therapy

    ;

    Steve K. Williams

    ;

    Sameer Chopra

    ;

    Farhang Rabbani

    ;

    12.4 Quality of Life With Brachytherapy for Low-Risk Localized Prostate Cancer

    ;

    Steve K. Williams

    ;

    Farhang Rabbani

    ;

    13 Role for Comparative Effectiveness Research in Treatment Decision Making

    ;

    Ryan T. Jones

    ;

    Mark V. Mishra

    ;

    Timothy N. Showalter

    ;

    14 Defining Treatment Failure for Localized Prostate Cancer: PSA and Beyond

    ;

    Nicholas G. Zaorsky

    ;

    Robert B. Den

    ;

    Jianqing Lin

    ;

    15 Prognosis After Biochemical Failure and Surrogate Endpoints for Prostate CancerñSpecific Mortality

    ;

    Peter Orio

    ;

    Nathan Bittner

    ;

    III.

    ;

    Treatment for High-Risk, Localized, and Locally Advanced Disease

    ;

    16 Treatment of High-Risk Prostate Cancer: The Role of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy

    ;

    Thomas J. Pugh

    ;

    IV.

    ;

    Treatment of Disseminated Disease

    ;

    17 Salvage Therapy for Rising PSA

    ;

    Judd W. Moul

    ;

    18 Metastatic Hormone Sensitive Prostate Cancer

    ;

    Jean Hoffman-Censits

    ;

    William Kevin Kelly

    ;

    19.1 Metastatic Castrate-Resistant Prostate Cancer: Mechanisms of Hormone Escape

    ;

    Susan F. Slovin

    ;

    19.2 Metastatic Castrate-Resistant Prostate Cancer: Role of Chemotherapy and Multifaceted Treatment Paradigms

    ;

    Abdel Hai Alqwasmi

    ;

    Nicholas G. Zaorsky

    ;

    Ulka Vaishampayan

    ;

    19.3 Metastatic Castrate-Resistant Prostate Cancer: Role of Androgen Signaling Inhibitors

    ;

    Austin Poole

    ;

    Ajjai Alva

    ;

    Julia Batten

    ;

    Neeraj Agarwal

    ;

    19.4.1 Radiation and the Immune System

    ;

    Andrew Sharabi

    ;

    Charles Drake

    ;

    19.4.2 Immunotherapy: Agents Targeting Prostate Cancer

    ;

    Gurveen Kaur

    ;

    Naveed H. Akhtar

    ;

    Beerinder K. Singh

    ;

    Scott T. Tagawa

    ;

    19.5 Treatment of Bony Metastases: Inhibitors of Bone Resorption

    ;

    Clara Hwang

    ;

    Elisabeth I. Heath

    ;

    19.6 Treatment of Bone Metastases: Radiopharmaceuticals

    ;

    Hossein Jadvar

    ;

    Leslie Ballas

    ;

    David I. Quinn

    ;

    19.7 Prognostication of Metastatic Castration-Resistant Prostate Cancer

    ;

    Alan D. Smith

    ;

    Joaquin Mateo

    ;

    Johann S. de Bono

    ;

    Index

    ;